Tharimmune, Inc.盘中异动快速上涨5.32%报1.30美元

市场透视2025-08-12

北京时间2025年08月12日02时10分，Tharimmune, Inc.（THAR.us）股票出现异动，股价快速上涨5.32%。截至发稿，该股报1.30美元/股，成交量1.09万股，换手率0.21%，振幅2.84%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.54百万美元，每股收益-0.99美元，毛利0.00美元，市盈率-0.16倍。机构评级方面，在所有1家参与评级的机构中，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2558624206?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-12 02:10","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2558624206","market":"us","top_or_hot":-1,"title":"Tharimmune, Inc.盘中异动 快速上涨5.32%报1.30美元","media":"市场透视","content":"<div>\n<p>北京时间2025年08月12日02时10分，Tharimmune, Inc.（THAR.us）股票出现异动，股价快速上涨5.32%。截至发稿，该股报1.30美元/股，成交量1.09万股，换手率0.21%，振幅2.84%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.54百万美元，每股收益-0.99美元，毛利0.00美元，市盈率-0.16倍。机构评级方面，在所有1家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tharimmune, Inc.盘中异动 快速上涨5.32%报1.30美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTharimmune, Inc.盘中异动 快速上涨5.32%报1.30美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-12 02:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年08月12日02时10分，Tharimmune, Inc.（THAR.us）股票出现异动，股价快速上涨5.32%。截至发稿，该股报1.30美元/股，成交量1.09万股，换手率0.21%，振幅2.84%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.54百万美元，每股收益-0.99美元，毛利0.00美元，市盈率-0.16倍。机构评级方面，在所有1家参与评级的机构中，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b","article_id":"2558624206","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021017a482685c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2558624206","pubTimestamp":1754935817,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年08月12日02时10分，Tharimmune, Inc.股票出现异动，股价快速上涨5.32%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Equillium, Inc.、Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6092.92%、628.08%、438.04%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","PBC":"Prospect Capital Corp"},"translate_title":"Tharimmune, Inc. rose 5.32% to $1.30 in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THAR":0.9,"PBC":1},"content_text":"北京时间2025年08月12日02时10分，Tharimmune, Inc.（THAR.us）股票出现异动，股价快速上涨5.32%。截至发稿，该股报1.30美元/股，成交量1.09万股，换手率0.21%，振幅2.84%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.54百万美元，每股收益-0.99美元，毛利0.00美元，市盈率-0.16倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Equillium, Inc.、Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6092.92%、628.08%、438.04%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。该公司正在朝着获取一种临床阶段资产的方向发展，该资产已知能够抑制原发性胆汁性胆管炎（PBC）中的慢性、使人衰弱的瘙痒或无法控制的瘙痒。原发性胆汁性胆管炎是一种罕见的孤儿肝病，目前尚无已知的治愈方法。公司的早期免疫肿瘤学研发管线包括针对多种实体瘤中经过验证的靶点的新型多特异性抗体，这些抗体针对具有新作用机制的表位。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2558624206","isCrawlerRequest":true}

Tharimmune, Inc.盘中异动 快速上涨5.32%报1.30美元

精彩评论

Tharimmune, Inc.盘中异动快速上涨5.32%报1.30美元